A number of bioreactor configurations have been developed for the manufacture of products from mammalian cell hosts. Even in the most efficient of these, however, problems such as nutrient exhaustion, growth factor deprivation, and toxin accumulations may arise. Consequently, the current effort focu
โฆ LIBER โฆ
Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults
โ Scribed by Bruno Figueroa Jr.; Tina M. Sauerwald; Alison J. Mastrangelo; J. Marie Hardwick; Michael J. Betenbaugh
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 605 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0006-3592
- DOI
- 10.1002/bit.1053
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Part II. Overexpression of bcl-2 family
โ
Alison J. Mastrangelo; J. Marie Hardwick; Shifa Zou; Michael J. Betenbaugh
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 348 KB
๐ 1 views
Aven and Bcl-xL enhance protection again
โ
Bruno Figueroa Jr.; Sulin Chen; George A. Oyler; J. Marie Hardwick; Michael J. B
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 784 KB
Bcl-2 leads to expression of anti-DNA B
โ
Philip Kuo; Margaret S. Bynoe; Chuansheng Wang; Betty Diamond
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 310 KB
MCL-1, a member of the BCL-2 family, is
โ
Tao Yang; Heather L. Buchan; Karen J. Townsend; Ruth W. Craig
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 1008 KB
mcl-1 was identified as an "early-induction" gene that increases in expression during the differentiation of ML-1 human myeloblastic leukemia cells. The mcl-1 gene product proved to be a member of the bcl-2 gene family and, like bcl-2, to have the capacity to promote cell viability. The pattern of e
The immunomodulatory drug lenalidomide r
โ
Carole Brosseau; Kay Colston; Angus George Dalgleish; Christine Galustian
๐
Article
๐
2011
๐
Springer
๐
English
โ 498 KB